European Drug Regulators Back First Gene Therapy Medicine

European drug regulators Friday recommended approval of gene therapy Glybera for patients with a rare genetic disorder.

BING NEWS:
  • Sangamo to regain rights to hemophilia A gene therapy
    Sangamo will regain full rights to giroctocogene fitelparvovec, a gene therapy candidate for hemophilia A, after Pfizer ended its program.
    01/7/2025 - 1:25 am | View Link
  • Gene Therapy Demonstrates High Efficacy in Severe β-Thalassemia
    A phase 3 trial highlights betibeglogene autotemcel as a potentially curative gene therapy for severe transfusion-dependent β-thalassemia.
    01/3/2025 - 6:09 am | View Link
  • First ever 'off the shelf' stem cell therapy nears European approval
    European regulators have ... ever allogeneic stem cell therapy approved in Europe, and will put the Belgium-based biotech company into the vanguard of cell and gene therapy companies which have ...
    01/2/2025 - 11:00 am | View Link
  • Pfizer kills hemophilia gene therapy deal, imperiling Sangamo
    Sangamo, a gene therapy pioneer, loses a financial lifeline as Pfizer drops a gene therapy program for hemophilia.
    12/31/2024 - 7:23 am | View Link
  • Sangamo Regains Rights to Hemophilia A Gene Therapy After Pfizer Ends Partnership
    Sangamo is seeking new partners to continue advancing giroctocogene fitelparvovec, which reported positive Phase III results this year.
    12/31/2024 - 3:29 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News